Member Info for Monkeytom

I agree with you. Also think the spike gives TB a better opportunity to offload, was thinking of buying back in, but think this is overpriced. Timeline to successful test/approvals and commercialisation may offer better buy in price, plus uncertainty of TBs actions.

I would be careful with RMS, lots of issues to resolve plus TB and infighting on BOD. Hopefully does well despite this as Cave seems decent. Sorry not related to EUA, just suggesting caution.

Well said Sanchez, also not very appealing for potential new investors looking in!

Pablo, could still 10 bag from here just to catch up with US valuations plus bitcoin rise, gla.

Have you actually read the RNS? If so I suggest you read again but only if you are an investor rather than day trader.

Why do you think that is an ouch?

Looking at there news are they correct to be excited or is the requirement for a high viral load a worry?